Aspira Women’s Health Expands Lab to Advance ENDOinform Test
Austin, Texas, USA – April 23, 2026 Aspira Women’s Health announced a major operational milestone with the expansion of...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas, USA – April 23, 2026 Aspira Women’s Health announced a major operational milestone with the expansion of...
Seattle, Washington, USA & Brisbane, Australia – April 23, 2026 Mozart Therapeutics announced positive interim Phase 1b clinical data...
